Abstract
In human atrium, serotonin (5-HT) exerts pleiotropic effects, which are thought to be mediated via 5-HT4 receptors. Here, we used transgenic mice (TG) that overexpress the human 5-HT4(a) receptor under control of the heart-specific α-myosin heavy chain promoter in the atria (and ventricles). Contractile studies were performed in isolated electrically driven left atrial preparations and spontaneously beating right atrial preparation of TG and littermate control mice (wild type (WT)). 5-HT increased force of contraction and phospholamban phosphorylation on serine 16 only in left atrial preparations from TG but not from WT. In contrast, β-adrenoceptor stimulation of left atrial preparations by isoprenaline increased force of contraction with similar pEC50 values and to a similar maximum extent in both TG and WT. The contractile effects of 5-HT in left atrial preparations from TG could be blocked by the 5-HT4 receptor-specific antagonists GR125487 or GR113808. In right atrial preparations from WT and TG, the β-adrenoceptor agonist isoprenaline exerted a positive chronotropic effect with similar pEC50 values and similar maximum effects. Only in right atrial preparations from TG but not WT, 5-HT exerted a positive chronotropic effect that could be attenuated by 5-HT4 receptor-specific antagonists. Finally, in left atrial preparations of TG, a higher incidence of arrhythmias was noted compared to WT. The present data indicate that the human 5-HT4 receptors expressed in mouse atria are functional. This is the first transgenic model to study this human receptor in the atrium ex vivo or in vivo.
Similar content being viewed by others
References
Bach T, Syversveen T, Kvingedal AM, Krobert KA, Brattelid T, Kaumann AJ, Levy FO (2001) 5-HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle. Naunyn Schmiedebergs Arch Pharmacol 363:146–160
Bers DM (2007) Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70:23–49
Bickmeyer U, Heine M, Manzke T, Richter DW (2002) Differential modulation of I(h) by 5-HT receptors in mouse CA1 hippocampal neurons. Eur J Neurosci 16:209–218
Blondel O, Vandecasteele G, Gastineau M, Leclere S, Dahmoune Y, Langlois M, Fischmeister R (1997) Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium. FEBS Lett 412:465–474
Blondel O, Gastineau M, Dahmoune Y, Langlois M, Fischmeister R (1998) Cloning, expression and pharmacology of four human 5-hydroxytryptamine4 receptor isoforms produced by alternative splicing in the carboxyl terminus. J Neurochem 70:2252–2261
Brattelid T, Kvingedal AM, Krobert KA, Andressen KW, Bach T, Hystad ME, Kaumann AJ, Levy FO (2004a) Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i). Naunyn Schmiedebergs Arch Pharmacol 369:616–628
Brattelid T, Qvigstad E, Lynham JA, Molenaar P, Aass H, Geiran O, Skomedal T, Osnes JB, Levy FO, Kaumann AJ (2004b) Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure. Naunyn Schmiedebergs Arch Pharmacol 370:157–166
Cardenas CG, Del Mar LP, Cooper BY, Scroggs RS (1997) 5-HT4 receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons. J Neurosci 17:7181–7189
De Maeyer JH, Straetemans R, Schuurkes JA, Lefebvre RA (2006) Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development. Br J Pharmacol 147:140–157
Du YD, Schoemaker RG, Bos E, Saxena PR (1994) Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue. Eur J Pharmacol 259:173–180
Engelhardt S, Hein L, Wiesmann F, Lohse MJ (1999) Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96:7059–7064
Engelhardt S, Grimmer Y, Fan GH, Lohse MJ (2001) Constitutive activity of the human beta(1)-adrenergic receptor in beta(1)-receptor transgenic mice. Mol Pharmacol 60:712–717
Galindo-Tovar A, Vargas ML, Escudero E, Kaumann AJ (2009) Ontogenic changes of the control by phosphodiesterase-3 and −4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors. Br J Pharmacol 156:237–249
Gergs U, Boknik P, Buchwalow I, Fabritz L, Matus M, Justus I, Hanske G, Schmitz W, Neumann J (2004) Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function. J Biol Chem 279:40827–40834
Gergs U, Neumann J, Simm A, Silber RE, Remmers FO, Läer S (2009) Phosphorylation of phospholamban and troponin I through 5-HT4-receptors in the isolated human atrium. Naunyn Schmiedebergs Arch Pharmacol 379:349–359
Gergs U, Baumann M, Böckler A, Buchwalow IB, Ebelt H, Fabritz L, Hauptmann S, Keller N, Kirchhof P, Klöckner U, Pönicke K, Rueckschloss U, Schmitz W, Werner F, Neumann J (2010) Cardiac overexpression of the human 5-HT4 receptor in mice. Am J Physiol Heart Circ Physiol 299:H788–H798
Grammer JB, Zeng X, Bosch RF, Kühlkamp V (2001) Atrial L-type Ca2+-channel, β-adrenoreceptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation. Basic Res Cardiol 96:82–90
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) IUPHAR classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157–203
Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554
Joubert L, Claeysen S, Sebben M, Bessis AS, Clark RD, Martin RS, Bockaert J, Dumuis A (2002) A 5-HT4 receptor transmembrane network implicated in the activity of inverse agonists but not agonists. J Biol Chem 277:25502–25511
Kaumann AJ (1990) Piglet sinoatrial receptors resemble human atrial 5-HT4-like receptors. Naunyn Schmiedebergs Arch Pharmacol 342:619–622
Kaumann AJ (1994) Do human atrial 5-HT4 receptors mediate arrhythmias? TiPS 15:451–455
Kaumann AJ, Levy FO (2006) 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther 111:674–706
Kaumann AJ, Sanders L (1994) 5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockade. Naunyn Schmiedebergs Arch Pharmacol 349:331–337
Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1990) A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 100:879–885
Kaumann AJ, Lynham JA, Brown AM (1996) Comparison of the densities of 5-HT4 receptors, β1- and β2-adrenoceptors in human atrium: functional implications. Naunyn Schmiedebergs Arch Pharmacol 353:592–595
Kirchhefer U, Baba HA, Hanske G, Jones LR, Kirchhof P, Schmitz W, Neumann J (2004) Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin. Am J Physiol 287:H2216–H2225
Kirchhefer U, Baba HA, Boknik P, Breeden KM, Mavila N, Brüchert N, Justus I, Matus M, Schmitz W, DePaoli-Roach AA, Neumann J (2005) Enhanced cardiac function in mice overexpressing protein phosphatase inhibitor-2. Cardiovasc Res 68:98–108
Kirchhof P, Fabritz L, Fortmuller L, Matherne GP, Lankford A, Baba HA, Schmitz W, Breithardt G, Neumann J, Boknik P (2003) Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor. Am J Physiol Heart Circ Physiol 285:H145–H153
Läer S, Remmers F, Scholz H, Stein B, Müller FU, Neumann J (1998) Receptor mechanism involved in the 5-HT-induced inotropic action in the rat isolated atrium. Br J Pharmacol 123:1182–1188
Lezoualc’h F, Steplewski K, Sartiani L, Mugelli A, Fischmeister R, Bril A (2007) Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillation. Biochem Biophys Res Commun 357:218–224
MacLennan DH, Kranias EG (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566–577
Neumann J, Boknik P, Matherne GP, Lankford A, Schmitz W (2003) Pertussis toxin sensitive and insensitive effects of adenosine and carbachol in murine atria overexpressing A1-adenosine receptors. Br J Pharmacol 138:209–217
Niu J, Vaiskunaite R, Suzuki N, Kozasa T, Carr DW, Dulin N, Voyno-Yasenetskaya TA (2001) Interaction of heterotrimeric G13 protein with an A-kinase-anchoring protein 110 (AKAP110) mediates cAMP-independent PKA activation. Curr Biol 11:1686–1690
Parker SG, Taylor EM, Hamburger SA, Vimal M, Kaumann AJ (1995) Blockade of human and porcine myocardial 5-HT4 receptors by SB 203186. Naunyn Schmiedebergs Arch Pharmacol 353:28–35
Pindon A, van Hecke G, van Gompel P, Lesage AS, Leysen JE, Jurzak M (2002) Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins. Mol Pharmacol 61:85–96
Pino R, Cerbai E, Calamai G, Alajmo F, Borgioli A, Braconi L, Cassai M, Montesi GF, Mugelli A (1998) Effect of 5-HT4 receptor stimulation on the pacemaker current I(f) in human isolated atrial myocytes. Cardiovasc Res 40:516–522
Pönicke K, Gergs U, Buchwalow IB, Hauptmann S, Neumann J (2012) On the presence of serotonin in mammalian cardiomyocytes. Mol Cell Biochem 365:301–312
Ponimaskin EG, Profirovic J, Vaiskunaite R, Richter DW, Voyno-Yasenetskaya TA (2002) 5-Hydroxytryptamine 4(a) receptor is coupled to the Galpha subunit of heterotrimeric G13 protein. J Biol Chem 277:20812–20819
Qvigstad E, Brattelid T, Sjaastad I, Andressen KW, Krobert KA, Birkeland JA, Sejersted OM, Kaumann AJ, Skomedal T, Osnes JB, Levy FO (2005) Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure. Cardiovasc Res 65:869–878
Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM (1995) Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 92:790–795
Sanders L, Kaumann AJ (1992) A 5-HT4-like receptor in human left atrium. Naunyn Schmiedebergs Arch Pharmacol 345:382–386
Sanders L, Lynham JA, Bond B, DelMonte F, Harding S, Kaumann AJ (1995) Sensitization of human atrial 5-HT4 receptors by chronic β-blocker treatment. Circulation 92:2526–2539
Saxena PR, Villalon CM (1991) 5-Hydroxytryptamine: a chameleon in the heart. Trends Pharmacol Sci 12:23–27
Simmerman HK, Jones LR (1998) Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78:921–947
Tramontana M, Giuliani S, Del Bianco E, Lecci A, Maggi CA, Evangelista S, Geppetti P (1993) Effects of capsaicin and 5-HT3 antagonists on 5-hydroxytryptamine-evoked release of calcitonin gene-related peptide in the guinea-pig heart. Br J Pharmacol 108:431–435
Villalon CM, De Boer M, Heiligers JAC, Saxena PR (1990) Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol 102:107–112
Acknowledgments
This study was supported by the Deutsche Forschungsgemeinschaft (DFG). The work was part of the medical thesis of Anne Böckler.
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gergs, U., Böckler, A., Ebelt, H. et al. Human 5-HT4 receptor stimulation in atria of transgenic mice. Naunyn-Schmiedeberg's Arch Pharmacol 386, 357–367 (2013). https://doi.org/10.1007/s00210-013-0831-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-013-0831-x